REPL- Replimune Group, Inc.

Name: Replimune Group, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. REPL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Astley-Sparke Philip	1.43M	$4.83M	-
CEO	Patel Sushil	533.6K	$1.80M	-
Other	Xynos Konstantinos	199.7K	$673.9K	-
CFO	Hill Emily Luisa	194.4K	$656.0K	-
Other	Schwendenman Andrew	78.3K	$264.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 13, 2023	Patel Sushil64	Chief Strategy Officer	Sell	5,698	$24.04	$137,008.27	-1.9%	-17.9%	-63.4%
May 16, 2023	Coffin Robert61	President &Chief R&D Officer	Sell	7,861	$18.05	$141,891.05	-0.4%	+6.5%	-63.2%
May 16, 2023	Lewis Tanya54	Chief Dev. Op. Officer	Sell	12,207	$18.05	$220,336.35	-7.6%	+6.5%	-63.2%
May 16, 2023	Love Colin72	Chief Operating Officer	Sell	10,775	$18.05	$194,488.75	-1.3%	+6.5%	-63.2%
May 16, 2023	Franchi Jean M.46	Chief Financial Officer	Sell	11,351	$18.05	$204,885.55	-8.1%	+6.5%	-63.2%
May 16, 2023	Xynos Konstantinos50	Chief Medical Officer	Sell	771	$18.05	$13,916.55	-0.6%	+6.5%	-63.2%
May 16, 2023	Esposito Pamela75	Chief Business Officer	Sell	5,966	$18.05	$107,686.30	-2.2%	+6.5%	-63.2%
May 16, 2023	Astley-Sparke Philip	Chief Executive Officer	Sell	17,902	$18.05	$323,131.10	-1.2%	+6.5%	-63.2%
May 16, 2023	Patel Sushil64	Chief Strategy Officer	Sell	15,575	$18.05	$281,128.75	-9.2%	+6.5%	-63.2%
Dec 9, 2022	Esposito Pamela75	Chief Business Officer	Sale+OE	15,000	$25.03	$375,450.00	-6.1%	-20.6%	-70.8%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC